PPT-De-escalation versus escalation of antiplatelet therapy in elderly ACS patients: insight

Deescalation versus escalation of antiplatelet therapy in elderly ACS patients insight from the ANTARCTIC trial Cayla G Cuisset T Lattuca B Silvain J Leclercq F Manzo Silberman S Pouillot. Tx. : . Real-World Practice. In the US, ~800,000 AF patients are on concomitant OAC and antiplatelet tx. 1. Patients on chronic OAC with CAD are 7x more likely to receive concomitant antiplatelet tx. Notothenioid. Fishes. by: Priscilla Watson-Wynn. Antarctica. Fifth largest continent. The world’s most southern continent. Surrounded by Southern Ocean. 98% covered in ice sheet & 2% barren rock. Working Group: . Maria E. Wolfs, MD, FRCP; . Rémi. . Rabasa-Lhoret. , MD, PhD. Canadian Cardiovascular Society Antiplatelet . Guidelines. Objectives. Interpret . the . Canadian Cardiovascular Society Guideline recommendations regarding the use of antiplatelet . GRACE. . 5-Year Mortality . Antiplatelet Therapy. Cornerstone of Medical Therapy Post ACS. TRA 2P-TIMI 50. Efficacy/Safety. ATLAS ACS 2—TIMI 51. Study Design. ATLAS-2. . Baseline Patient Characteristics. Giorgio V. Scagliotti. University. of . Torino,. . Department. . of . Oncology. giorgio.scagliotti@unito.it. Key. . points. of the . presentation. Incidence. Age . cut. -off. Comorbidity. & . Territorial Disputes in Antarctica an be traced to the first formal claim made. b. y Great Britain in 1908. It began when W. S. Bruce let a Scottish National Antarctic Expedition to . Laurie Island in the South Orkneys in 1902-1904. Antiplatelet Guidelines. . ANTIPLATELET THERAPY IN PATIENTS WITH CHRONIC KIDNEY DISEASE. Working. Group: . Neesh. . Pannu. , MD, SM, FRCP; Alan D. Bell, MD, CCFP. Interpret the Canadian Cardiovascular Society Guideline recommendations regarding the use antiplatelet . Minilecture. Objectives. Indications for Antiplatelet Therapy in patients with CAD and ACS. Antiplatelet Therapy in the role of primary and secondary prevention of . c. ardiovascular events. CAD & the Vulnerable Plaque. Minilecture. Objectives. Indications for Antiplatelet Therapy in patients with CAD and ACS. Antiplatelet Therapy in the role of primary and secondary prevention of . c. ardiovascular events. CAD & the Vulnerable Plaque. Tiri. Maria . Enrica. . Antoniucci. . Maria Calabrese. Raffaella. . Marocco. . Rozeen. . Esvan. Cluster 8. : 10-11 . Ottobre. 2019. De-escalation o . streamlining. Riduzione dello spettro antimicrobico: . Akhtar . Fajar. . Muzakkir. New ESC NSTEMI Guideline. Collet JP et al European Heart Journal (2020) 00, 1-79 . What is NEW?. Collet JP et al European Heart Journal (2020) 00, 1-79 . Major Changes in Recommendation. John King and Thomas Bracegirdle. British Antarctic Survey. Cambridge, UK. jcki@bas.ac.uk. S. tart presentation. Introduction to the Antarctic coastal . e. asterlies. Climatology of the Antarctic coastal . 12. inhibitor to dual pathway inhibition with aspirin plus vascular-dose rivaroxaban: The Switching Anti-Platelet and Anti-Coagulant Therapy (SWAP-AC) Study. Luis Ortega-Paz, MD, PhD. 1. ; Francesco Franchi, MD. intracerebral haemorrhage (ICH): extended follow-up of the. RE. start. or . ST. op. . A. ntithrombotics. . R. andomised . T. rial. (RESTART) . RESTART Collaboration. www.RESTARTtrial.org. Intracerebral haemorrhage (ICH) is associated with an increased risk of arterial ischaemic events*: pooled analysis of 4 population-based cohorts.